CN1263768A - Chinese-medicinal oral nerve growth liquid - Google Patents
Chinese-medicinal oral nerve growth liquid Download PDFInfo
- Publication number
- CN1263768A CN1263768A CN 99120671 CN99120671A CN1263768A CN 1263768 A CN1263768 A CN 1263768A CN 99120671 CN99120671 CN 99120671 CN 99120671 A CN99120671 A CN 99120671A CN 1263768 A CN1263768 A CN 1263768A
- Authority
- CN
- China
- Prior art keywords
- radix
- gross weight
- accounts
- ganqizi
- fructus jujubae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An oral liquid for treating peripheral nerve injury and neuron retromorphosis is prepared from 6 Chinese-medicinal materials including astragalus root, pilose asiabell root, raw white atractylodes rhizome, fleece flower root, etc. through removing impurities, drying, pulverizing, screening mixing, immersing in water, digestion, filter, concentrating, alcohol extraction, mixing and concentrating. Its advantages is sure curative effect.
Description
What the present invention relates to is a kind of herb mixture nerve growth decoction oral liquid for the treatment of illness such as nerve injury, neuron degeneration.
Adopt illness such as Chinese herbal treatment nerve injury, though long history is arranged, but because of prescription composition complexity, kind come out one after another, efficacy determination differs, be difficult to scale development and apply, there is a kind of medicine for the treatment of illness such as nerve injury to claim nerve growth factor abroad, belongs to Western medicine, cost an arm and a leg, use inconvenience, curative effect is also unsatisfactory.
The objective of the invention is to the defective at above-mentioned existence, propose a kind of herb mixture-nerve growth decoction, it can effectively treat illness such as nerve injury, neuron degeneration.
Technical solution of the present invention: its proportioning components: the Radix Astragali accounts for the 20-30% of gross weight, 20-25%, the 15-20% that Rhizoma Atractylodis Macrocephalae accounts for gross weight, 9-12%, the 15-20% that GANQIZI accounts for gross weight, the 11-15% that Radix Angelicae Sinensis accounts for gross weight that Radix Polygoni Multiflori accounts for gross weight that Radix Codonopsis accounts for gross weight.
Its composition also can increase Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, and they respectively account for the Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, 8-12%, the 5-10% of Radix Angelicae Sinensis gross weight, 5-10%.Increase Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati are to adapt to better people's taste.
The production craft step branch (1) of herb mixture nerve growth decoction oral liquid is if need promptly get above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, put, reject impurity respectively in order, and dried, make its water content reach 5-6%; (2) each composition is weighed to scale; (3) pulverize with pulverizer, 60 orders sieve; (4) if need be with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, the 3-5 water logging doubly that adds its gross weight after also only the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, GANQIZI, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi being mixed was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram left and right sides crude drug; (5) with the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram left and right sides crude drug; (7) packing.
Advantage of the present invention:
This mixture belongs to pure Chinese medicinal preparation, it be in tradition on the basis of proved recipe, utilization modern biology technology is carried out the effect experiment of cellular level to its component, filter out and be rich in the active ingredient that promotes nerve growth, be combined into a kind of novel oral mixture according to Chinese medical theory, take and the result of preliminary clinic trial shows through the SD of sciatic nerve injury rat, this mixture has tangible promotion injured nerve repairing growth, promote the effect of functional rehabilitation, measure through toxicity test, this mixture toxicity is humble, any side effect do not occur, the clinical scope of application: refreshing on every side damage, illness such as neuron degeneration.Its active ingredient is definite, curative effect is clear and definite, clinical quantitative criteria, can scale development and apply.
Embodiment 1
Get 4 kilograms of the Radixs Astragali, 3 kilograms of Radix Codonopsis, 2.5 kilograms of Rhizoma Atractylodis Macrocephalae, 1.9 kilograms of Radix Polygoni Multiflori, GANQIZI 2..5 kilogram, Radix Angelicae Sinensis 2..1 kilogram
Production craft step branch (1) is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, Radix Angelicae Sinensis, puts, rejects impurity respectively in order, and dried, makes its water content reach 5%; (2) each composition is weighed to scale; Get 3 kilograms of the Radixs Astragali, 2 kilograms of Radix Codonopsis, 1.5 kilograms of Rhizoma Atractylodis Macrocephalae, 0.9 kilogram of Radix Polygoni Multiflori, 1.5 kilograms of GANQIZI, 1.1 kilograms of Radix Angelicae Sinensis; (3) pulverize with pulverizer, 60 orders sieve; (4) only soaked 24 hours adding 30 kg of water after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, the GANQIZI mixing, carry out under the normal temperature condition, after steaming and decocting made its boiling then, constant temperature 60 minutes carried out the screen plate filter and remove residue again, concentrated, and every milliliter reaches 0.6 gram crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram crude drug; (7) packing.
Embodiment 2
Get 3 kilograms of the Radixs Astragali, 3.3 kilograms of Radix Codonopsis, 2.7 kilograms of Rhizoma Atractylodis Macrocephalae, 2 kilograms of Radix Polygoni Multiflori, 2.7 kilograms of GANQIZI, 2.3 kilograms of Radix Angelicae Sinensis.
Increase by 1.9 kilograms of Fructus Jujubaes, 2.0 kilograms of Radix Et Caulis Acanthopanacis Senticosis, Rhizoma Polygonati 2..0 kilogram,
Production craft step branch (1) is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, puts, rejects impurity respectively in order, and dried, makes its water content reach 6%; (2) get 2 kilograms of the Radixs Astragali, 2.3 kilograms of Radix Codonopsis, 1.7 kilograms of Rhizoma Atractylodis Macrocephalae, 1 kilogram of Radix Polygoni Multiflori, 1.7 kilograms of GANQIZI, 1.3 kilograms of Radix Angelicae Sinensis.Increase by 0.9 kilogram of Fructus Jujubae, 1.0 kilograms of Radix Et Caulis Acanthopanacis Senticosis, 1.0 kilograms of Rhizoma Polygonatis, (3) each composition is pulverized with pulverizer, and 60 orders sieve; (3) water logging that adds 64.5 kilograms after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, GANQIZI, Fructus Jujubae, the Radix Et Caulis Acanthopanacis Senticosi mixing was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram left and right sides crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram left and right sides crude drug; (7) packing
Claims (3)
1, herb mixture nerve growth decoction oral liquid, it is characterized in that its proportioning components: the Radix Astragali accounts for the 20-30% of gross weight, 20-25%, the 15-20% that Rhizoma Atractylodis Macrocephalae accounts for gross weight, 9-12%, the 15-20% that GANQIZI accounts for gross weight, the 11-15% that Radix Angelicae Sinensis accounts for gross weight that Radix Polygoni Multiflori accounts for gross weight that Radix Codonopsis accounts for gross weight.
2, herb mixture nerve growth decoction oral liquid according to claim 1, the institute's composition that it is characterized in that it also can increase Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, and they respectively account for the Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, 8-12%, the 5-10% of Radix Angelicae Sinensis gross weight, 5-10%.
3, the production technology of herb mixture nerve growth decoction oral liquid, it is characterized in that its processing step branch (1) is if need promptly get above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, GANQIZI, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, put, reject impurity respectively in order, and dried, make its water content reach 5-6%; (2) each composition is weighed to scale; (3) pulverize with pulverizer, 60 orders sieve; (4) if need be with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, the 3-5 water logging doubly that adds its gross weight after also only the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, GANQIZI, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi being mixed was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram left and right sides crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram left and right sides crude drug; (7) packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99120671A CN1086299C (en) | 1999-12-29 | 1999-12-29 | Chinese-medicinal oral nerve growth liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99120671A CN1086299C (en) | 1999-12-29 | 1999-12-29 | Chinese-medicinal oral nerve growth liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1263768A true CN1263768A (en) | 2000-08-23 |
| CN1086299C CN1086299C (en) | 2002-06-19 |
Family
ID=5281635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99120671A Expired - Lifetime CN1086299C (en) | 1999-12-29 | 1999-12-29 | Chinese-medicinal oral nerve growth liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1086299C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105596978A (en) * | 2015-12-23 | 2016-05-25 | 薛学明 | Drug for treating nerve injury and preparation method thereof |
| CN111759915A (en) * | 2020-07-20 | 2020-10-13 | 南通大学 | Nerve regeneration compound preparation and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048408C (en) * | 1994-06-14 | 2000-01-19 | 鲁守龙 | Medicine for curing nervous system injury and angionosis |
| CN1156608A (en) * | 1996-12-10 | 1997-08-13 | 艾津华 | Chinese medicine for treating nerve system disease and producing process thereof |
-
1999
- 1999-12-29 CN CN99120671A patent/CN1086299C/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105596978A (en) * | 2015-12-23 | 2016-05-25 | 薛学明 | Drug for treating nerve injury and preparation method thereof |
| CN111759915A (en) * | 2020-07-20 | 2020-10-13 | 南通大学 | Nerve regeneration compound preparation and preparation method and application thereof |
| WO2022016827A1 (en) * | 2020-07-20 | 2022-01-27 | 南通大学 | Compound preparation for neuranagenesis, and preparation method therefor and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1086299C (en) | 2002-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102335335A (en) | Traditional Chinese medicine preparation with effects of health care and physical fatigue alleviation | |
| CN101455791A (en) | Pure traditional Chinese medicine preparation for treating hyperlipemia | |
| CA2467444A1 (en) | Medicament for treatment of climacteric syndrome of women and preparation method thereof | |
| CN1785284B (en) | Medicinal composition containing flowery knotwood root | |
| CN101279012A (en) | Chinese medicine tea for weight reduction, toxin elimination and beauty treatment and matching Chinese medicinal composition | |
| CN104383461A (en) | Chinese medicinal composition for treating insomnia due to blood stasis | |
| CN1086299C (en) | Chinese-medicinal oral nerve growth liquid | |
| CN112076293A (en) | Preparation method of moxa stick for improving physique | |
| CN1065272C (en) | Zhenlongyin tourist wine | |
| CN105456809A (en) | Traditional Chinese medicine composition for treating hypertension, hyperglycemia and hyperlipidemia | |
| CN1240655A (en) | Face-nursing stigma croci tea and its making method | |
| CN104689042A (en) | Traditional Chinese medicine for treating female menopause insomnia | |
| CN102397404B (en) | Tea paste for treating limb anesthesia dolorosa and preparation method thereof | |
| LU502953B1 (en) | A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN107898968A (en) | Chinese medicinal preparation method with health-care effect | |
| CN105920450A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN115814048A (en) | Chinese medicine for treating rheumatism and its preparation | |
| CN113058003A (en) | Liqueur and preparation method and application thereof | |
| CN101259204B (en) | Medicaments for treating and preventing hypertension and preparation thereof | |
| CN101062134A (en) | Medicine and medical wine for treating hemiplegia | |
| CN105106578A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method of traditional Chinese medicine composition | |
| CN1116052C (en) | 'Yidaosheng' capsules | |
| CN115192666A (en) | Kidney-tonifying health-care medicinal liquor and preparation method thereof | |
| CN116712511A (en) | Preparation method of medicine for reducing weight | |
| CN114099615A (en) | Medicament for treating myasthenia gravis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20020619 |
|
| CX01 | Expiry of patent term |